Ralf A. Linker

8.1k total citations
71 papers, 2.4k citations indexed

About

Ralf A. Linker is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Ralf A. Linker has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 18 papers in Neurology and 15 papers in Immunology. Recurrent topics in Ralf A. Linker's work include Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (6 papers). Ralf A. Linker is often cited by papers focused on Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (6 papers). Ralf A. Linker collaborates with scholars based in Germany, United States and Switzerland. Ralf A. Linker's co-authors include Ralf Gold, Dominik N. Müller, Markus Kleinewietfeld, Arndt Manzel, Fred Lühder, De-Hyung Lee, Susan E. Erdman, David A. Hafler, Martin Stangel and Anne Waschbisch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature reviews. Immunology.

In The Last Decade

Ralf A. Linker

67 papers receiving 2.3k citations

Peers

Countries citing papers authored by Ralf A. Linker

Since Specialization

Citations

This map shows the geographic impact of Ralf A. Linker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf A. Linker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf A. Linker more than expected).

Fields of papers citing papers by Ralf A. Linker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf A. Linker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf A. Linker. The network helps show where Ralf A. Linker may publish in the future.

Co-authorship network of co-authors of Ralf A. Linker

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf A. Linker. A scholar is included among the top collaborators of Ralf A. Linker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf A. Linker. Ralf A. Linker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals 2025 ·EBioMedicine ·(unknown), Michael G. Kaiser, D. Freudenstein, (unknown), Katja Dettmer, Peter J. Oefner, Gerhard Liebisch, Andreas Hiergeist, André Gessner, (unknown), Klemens Angstwurm, Ralf A. Linker, Stefanie Haase	0
2	Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosis 2025 ·Journal of the Neurological Sciences ·(unknown), D. Freudenstein, (unknown), Klemens Angstwurm, Ralf A. Linker, De-Hyung Lee	1
3	Clinical Course and Recurrence in Transient Global Amnesia: A Study From the TEMPiS Telestroke Network 2023 ·Journal of Clinical Neurology ·(unknown), Nils Peters, Annaelle Zietz, (unknown), G. Hubert, Filip Barinka, (unknown), (unknown), Ralf A. Linker, Felix Schlachetzki, Roland Backhaus	3
4	Immuntherapie und personalisierte Behandlung bei Multipler Sklerose 2021 ·Der Nervenarzt ·Ralf A. Linker, Ralf Gold	3
5	Oral Health, Oral Microbiota, and Incidence of Stroke-Associated Pneumonia—A Prospective Observational Study 2020 ·Frontiers in Neurology ·Fabian Cieplik, (unknown), (unknown), Karl‐Anton Hiller, Andreas Hiergeist, Andrea Wagner, Dobri Baldaranov, Ralf A. Linker, Jonathan Jantsch, Wolfgang Buchalla, Felix Schlachetzki, André Gessner	31
6	Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits? 2020 ·Journal of the Neurological Sciences ·(unknown), (unknown), Kathrin S. Utz, Florian T. Nickel, De-Hyung Lee, Ralf A. Linker	2
7	Navigating choice in multiple sclerosis management 2019 ·SHILAP Revista de lepidopterología ·Ralf A. Linker, Andrew Chan	12
8	Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis 2018 ·Journal of Neurology ·(unknown), Klemens Winder, Ralf A. Linker, Konstantin Huhn, Tobias Engelhorn, Arnd Dörfler, De‐Hyung Lee, Stefan Schwab, Frank Seifert	6
9	Insular multiple sclerosis lesions are associated with erectile dysfunction 2018 ·Journal of Neurology ·Klemens Winder, Ralf A. Linker, Frank Seifert, (unknown), Tobias Engelhorn, Arnd Dörfler, De‐Hyung Lee, Katharina M. Hösl, Max J. Hilz	20
10	Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis 2017 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Claus Jürgen Scholz, Stefanie Jörg, Ralf A. Linker, Erhard Wischmeyer, Marie Wunsch, Johannes Hell, Süleyman Ergün, Stefanie Küerten	52
11	FLAIRfusion Processing with Contrast Inversion 2017 ·Clinical Neuroradiology ·Manuel Schmidt, Ralf A. Linker, Stefan Lang, Hannes Lücking, Tobias Engelhorn, Stephan Kloska, Michael Uder, Alexander Cavallaro, Arnd Dörfler, Peter Dankerl	9
12	Immunomodulatory effects of oral dimethyl fumarate on intestinal immune regulation during experimental autoimmune neuritis in Lewis rats (P2.357) 2017 ·Neurology ·Jeremias Motte, Kalliopi Pitarokoili, (unknown), (unknown), Björn Ambrosius, Ralf A. Linker, Ralf Gold	0
13	Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study 2016 ·Neurology and Therapy ·Ralf A. Linker, (unknown)	8
14	Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney 2016 ·Scientific Reports ·Oliver Domenig, Arndt Manzel, Nadja Grobe, Eva Königshausen, Christopher C. Kaltenecker, J Kovarík, Johannes Stegbauer, Susan B. Gurley, (unknown), Marlies Antlanger, Michael Bäder, Daisy Motta‐Santos, Robson A.S. Santos, Khalid M. Elased, Marcus D. Säemann, Ralf A. Linker, Marko Poglitsch	70
15	Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease 2014 ·Journal of Neuroimmune Pharmacology ·Arndt Manzel, Oliver Domenig, (unknown), Ágnes Zsófia Kovács, Johannes Stegbauer, Marko Poglitsch, Dominik Mueller, Ralf Gold, Ralf A. Linker	2
16	Advancing therapeutic options in multiple sclerosis with neuroprotective properties 2013 ·Journal of Neural Transmission ·(unknown), Ralf A. Linker, Ralf Gold	5
17	Fingolimod-Compassionate-use-Programm 2012 ·Der Nervenarzt ·Jürgen Haas, Ralf A. Linker, H.‐P. Hartung, (unknown), Sonja Ortler, Ferenc Tracik	1
18	Inflammation modulates anxiety in an animal model of multiple sclerosis 2011 ·Behavioural Brain Research ·(unknown), (unknown), Jan Thöne, Bernhard T. Hovemann, Ralf Gold, Georg Juckel, Ralf A. Linker	75
19	Cyclooxygenase-2 is a neuronal target gene of NF-κB 2002 ·BMC Molecular Biology ·Barbara Kaltschmidt, Ralf A. Linker, Jinbo Deng, Christian Kaltschmidt	93
20	Cloning of the murine relA (p65 NF-κB) gene and comparison to the human gene reveals a distinct first intron 1996 ·Gene ·Ralf A. Linker, Patrick A. Baeuerle, Christian Kaltschmidt	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact